SEARCH BY NAME

BROWSE

Browse Australian delisted companies

0-9A BC DE F GH IJ KL MN OP QR ST UV WX YZ

Browse terminated Australian managed funds

0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

UNILIFE CORPORATION (UNS)

Delisted from ASX 28/08/2017

Former (or subsequent) names

 

Shareholder links

Our website ranking of UNS: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Computershare, Level 2, 45 St Georges Terrace, Perth WA 6000
Tel : +61 8 9323 2000 or 1300 557 010
Fax : +61 8 9323 2033
RegistryWebsite RegistryEmail

Company details

ISIN: w
Address: 250 Cross Farm Lane, York, PEN, U.S.A., 17406
Tel:  (02) 8346 6500 Fax: (02) 8346 6511

Date first listed: 18/01/2010
Company Secretary: John Ryan
Sector: Health Care Equipment & Services Industry Group: XHJ
Activities: The Company is the successor entity to Unilife Medical Solutions Limited. The Company develops and supplies innovative safety medical devices
Strike-Off Action In Progress25/01/2018
delisted from the close of trading on Monday 28 August 2017 pursuant to Listing Rule 17.15.28/08/2017
we understand the company failed to pay its annual listing fee following bankruptcy in the US and ASX removed it from listing28/08/2017
Under listing rule 17.6, any entity (if not already suspended) that had not paid its annual listing fees by close of business on Monday 21 August 2017 will have its securities suspended from official quotation before the commencement of trading on Tuesday 22 August 2017. The company has failed to pay to ASX Limited the annual listing fees in respect of the year ending 30 June 2018 and consequently will have its securities suspended from quotation immediately.22/08/2017
The company files a Form 8-K with the SEC which details the transfer of the assets of the business of Unilife Corporation and its subsidiaries to its secured creditors under Chapter 11 bankruptcy proceedings in the US. Following completion of the transfer of the assets, the Company and its subsidiaries no longer have any material assets and the Company intends to apply to delist from ASX shortly.03/08/2017
On June 22, 2017, the Company submitted to the Bankruptcy Court its monthly financial reports for itself and its U.S. subsidiaries for the month ended May 31, 2017.27/06/2017
The company releases an 8-K Chapter 11 April Statement.05/06/2017
On April 21, 2017, Unilife Corporation received notification from KPMG LLP, the Company's independent registered public accounting firm, advising the Company of KPMG's resignation as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2017, effective immediately. 28/04/2017
On April 12, 2017, Unilife Corporation received a letter from The NASDAQ Stock Market LLC stating that in accordance with NASDAQ Listing Rules 5101, 5110(b) and IM-5101-1, NASDAQ has determined that the Company's common stock will be delisted from NASDAQ. 18/04/2017
The securities of Unilife Corporation will be suspended from official quotation immediately, at the request of the Company pursuant to listing rule 17.2, following the Company having filed voluntary petitions in the United States Bankruptcy Court for the District of Delaware for relief under Chapter 11 of the United States Bankruptcy Code. 13/04/2017
The suspension of trading in the securities of Unilife Corporation will be lifted from the commencement of trading on Wednesday 26 October 2016 following receipt of its audited financial statements for the financial year ended 30 June 2016. 25/10/2016
The company releases its Amended 2015 10-K, Amended 10-Q (30.09.15), Amended 10-Q (31.12.15), 8-K (17.10.16), and 2016 10-K Annual Report25/10/2016
The company releases its Form 10-Q.25/10/2016
The company releases its 8-K Amgen & OrbiMed Waivers.06/10/2016
The securities of Unilife Corporation Limited will be suspended from official quotation immediately at the request of the Company, pending the release of an announcemen30/09/2016
listed entity carried for record purposes only18/01/2010

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNATURENUMBERPRICEAMOUNT
    13/02/2012Alan ShortallOn market USD6,400$3.680$23,558
    03/02/2012Alan ShortallOn market USD10,000$3.900$38,965
    26/01/2012Alan ShortallOn market USD1,000$4.060$4,060
    24/01/2012Alan ShortallOn market USD15,000$4.069$61,038
    22/01/2012Alan ShortallOn market USD10,000$4.030$40,276

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Mary WoldChairman, Independent Director11/05/2010
    Ian HansonVice President, COO01/08/2011
    Jack KelleyVice President11/08/2011
    Christopher NaftzgerVice President, General Counsel07/07/2010
    Michael RatiganVice President01/03/2011
    Dennis PyersCFO19/03/2014
    Jeff CarterNon Exec Director, Local Agent01/04/2006
    Marc FirestoneNon Exec Director27/07/2010
    William GalleNon Exec Director05/11/2009
    John LundNon Exec Director05/11/2009
    Harry HamillDirector26/08/2015
    John C. RyanDirector, CEO14/03/2016
    Michael KamarckDirector29/07/2016
    Rosemary CraneDirector01/11/2016
    Duane DeSistoDirector01/11/2016
    Stephen AllanInvestor Relations

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    David HastingsCFO23/02/201509/06/2017
    Alan ShortallChairman, CEO02/07/200911/03/2016
    Ramin MojdehCOO25/11/201311/03/2016
    Jim BosnjakDeputy Chairman, COO01/02/200326/08/2015
    Richard WielandCFO10/06/201019/03/2014
    David RiekieChairman20/09/200221/04/2006
    Stanley McLieshNon Exec Director12/05/200410/03/2006
    David McIntyreCFO19/12/200325/02/2005
    Jeremy ShervingtonNon Exec Director15/07/200220/09/2002
    Adam Rankine-WilsonNon Exec Director15/07/200220/09/2002
    Alan CoulthardNon Exec Director15/07/200220/09/2002
    John HolmanNon Exec Director15/07/2002
    Leo RespingerNon Exec Director15/07/2002
    Steven KoppeNon Exec Director15/07/2002
    Hugh McLernonChairman10/10/2001
    Andrew DrummondManaging Director19/09/2001

    Date of first appointment, title may have changed.